Orthofix appoints new president of global spine business
Click Here to Manage Email Alerts
Key takeaways:
- Orthofix appointed Max Reinhardt as president of its global spine business.
- Reinhardt will join the executive leadership team of the company and oversee SeaSpine, its global spine and biologics business.
Orthofix Medical Inc. appointed Max Reinhardt as the new president of its global spine business, effective June 10, according to a company press release.
“I am delighted to have the opportunity to lead the talented spine team at Orthofix as we continue to innovate and introduce differentiated products and procedurally integrated solutions to the market to solve complex spine problems,” Reinhardt said in the release. “I believe the company has a strong foundation and is well positioned for growth in the years ahead. I look forward to working with our dedicated team members to deliver new product solutions and provide exceptional support for our surgeon customers and their patients.”
Reinhardt, who most recently held a leadership position at Pacira Biosciences, will also join the executive leadership team of Orthofix and oversee SeaSpine, its global spine and biologics business.
Reinhart has held leadership positions at Johnson & Johnson, Steris and Olympus, and DePuy Synthes.
“Max brings strong leadership and a proven track record of success to our global spine business,” Massimo Calafiore, president and CEO of Orthofix, said in the release. “He brings a wealth of experience in driving innovation while continually executing focused strategies to drive commercial success. I look forward to the guidance and expertise he will bring to our organization as we continue to accelerate and position Orthofix as one of the leading spine companies in the market.”
Read more about
Click Here to Manage Email Alerts